PRP Injections for Plantar Fasciitis: Do They Work Better Than Cortisone?
- 6 days ago
- 6 min read
Updated: 5 days ago
Medically reviewed by Dr. Jeffrey Peng, MD — Board-Certified Sports Medicine Physician
Last updated: February 28, 2026
Plantar fasciitis is one of the most common and frustrating conditions I see in my sports medicine practice. Many of my patients have already tried stretching, orthotics, night splints, and even steroid injections — only to have their heel pain return weeks or months later. The question I hear most often is whether there is a treatment that can actually heal the damaged tissue rather than just temporarily relieving the pain. That is exactly what platelet-rich plasma (PRP) injections aim to do, and a growing body of research suggests they may deliver on that promise.
In this article, I will explain why chronic plantar fasciitis is so difficult to treat, how PRP works at the cellular level, and what the latest meta-analyses tell us about how PRP compares to corticosteroid injections for long-term heel pain relief.
Why Is Plantar Fasciitis So Hard to Heal?
The plantar fascia is a thick band of connective tissue that runs along the bottom of the foot, supporting the arch and absorbing impact with every step you take. When it is overloaded — whether from repetitive stress, poor footwear, biomechanical issues like flat feet, or tight calf muscles — it can develop microscopic tears and progressive degeneration.
In the early stages, the body mounts an inflammatory response to repair this damage, which is why most acute cases improve with rest, stretching, and orthotics. However, when the condition becomes chronic, that normal healing process breaks down. The tissue becomes weaker, stiffer, and less capable of tolerating load. Histologically, chronic plantar fasciitis is characterized more by degenerative changes than active inflammation, which is why treatments that target inflammation alone often fall short of providing lasting relief.
According to a comprehensive review in Foot & Ankle Orthopaedics, approximately 90% of plantar fasciitis cases resolve with conservative treatment within 3 to 6 months. But for the remaining patients whose symptoms persist, finding an effective next step becomes critically important (Latt et al., 2020).
The Problem with Corticosteroid Injections
Traditionally, corticosteroid injections have been the go-to treatment for plantar fasciitis that does not respond to first-line conservative care. Steroid injections are effective at calming inflammation and providing rapid pain relief in the short term. However, they do not actually repair the damaged tissue. The underlying degenerative changes in the fascia remain, which is why the pain frequently returns once the anti-inflammatory effects wear off.
More concerning is that repeated corticosteroid injections carry real risks. Studies have documented complications including plantar fascia rupture and fat pad atrophy — the gradual thinning of the cushioning layer beneath the heel that can create a new source of chronic pain (Latt et al., 2020). These risks make steroid injections a less attractive option for long-term management, particularly in patients with chronic or recurrent heel pain.
How Do PRP Injections Work for Plantar Fasciitis?
Platelet-rich plasma takes a fundamentally different approach. Instead of simply suppressing inflammation, PRP aims to stimulate healing at the cellular level. The process begins with drawing a small sample of the patient's own blood and spinning it in a centrifuge to concentrate the platelets. These concentrated platelets contain a rich supply of growth factors and cytokines — signaling molecules that activate the body's natural repair mechanisms.
When injected into the damaged plantar fascia, PRP delivers these growth factors directly to the site of injury. They attract repair cells to the area, promote new collagen formation to strengthen the weakened tissue, and stimulate angiogenesis — the growth of new blood vessels that improve nutrient delivery to the healing tissue. In essence, PRP works with your body's biology rather than against it, encouraging genuine tissue regeneration rather than just masking symptoms.
What Does the Research Say? PRP vs. Corticosteroid Injections
A 2025 meta-analysis published in Foot & Ankle Specialist compiled data from 13 randomized controlled trials involving 901 patients, directly comparing PRP injections to corticosteroid injections for plantar fasciitis. Each study measured changes in pain using the Visual Analog Scale (VAS).
In the short term — approximately one month after treatment — both PRP and corticosteroid injections performed similarly well. Patients in both groups reported significant reductions in heel pain, typically dropping two to three points on a ten-point pain scale. At this early stage, there was no statistically significant difference between the two treatments.
However, by the medium-term follow-up at six months, the difference became clear. Patients who received PRP continued to improve, while those who had corticosteroid injections saw their pain begin to return. The PRP group demonstrated statistically significant superiority over the corticosteroid group in VAS pain scores (p < 0.00001). Importantly, across all 13 studies, there were no major adverse events reported with PRP — no infections, no worsening pain, and no fascia ruptures.
Corroborating Evidence from Additional Meta-Analyses
These findings are consistent with a larger 2025 meta-analysis of 24 randomized controlled trials involving 1,653 participants published in the American Journal of Physical Medicine & Rehabilitation. That analysis found PRP injections yielded significantly better pain scores compared to corticosteroid injections at 3 months and 6 months, with no significant difference at the 1-month mark. PRP was also superior in functional outcome scores (AOFAS scores) at 3, 6, and 12 months.
Additionally, a broad meta-analysis of 56 randomized controlled trials on PRP for chronic pain conditions found that PRP was associated with statistically significant pain reduction compared to corticosteroid injections across multiple conditions (SMD = -0.53, p = 0.02), with the greatest benefits emerging at follow-up periods of 3 months or longer. This reinforces a consistent pattern: PRP may not outperform steroids in the first few weeks, but its regenerative effects build over time to produce more durable outcomes.
Why PRP Outperforms Steroids Over Time
The divergence in outcomes between PRP and corticosteroids makes biological sense when you consider how each treatment works. Corticosteroid injections are potent anti-inflammatory agents that rapidly suppress pain and swelling, but they do nothing to address the underlying tissue degeneration. Once the steroid effect fades, the damaged fascia remains just as vulnerable as before.
PRP, by contrast, delivers concentrated growth factors that stimulate new collagen synthesis, restore blood flow to the injured tissue, and promote genuine structural repair. This healing process takes time — which explains why PRP does not provide faster relief than steroids in the first month — but the tissue remodeling that occurs over the following weeks and months produces improvements that are more sustained and meaningful.
Is PRP Right for Your Plantar Fasciitis?
Based on the current evidence, PRP is a safe and effective treatment option for chronic plantar fasciitis, particularly for patients who have not responded to conservative treatments such as stretching, physical therapy, orthotics, and activity modification. It is especially worth considering if you have already had one or more steroid injections with only temporary relief, or if you want to avoid the potential complications associated with repeated corticosteroid use.
That said, PRP is not a standalone cure. What you do after the injection matters enormously. A structured rehabilitation protocol — including gradual return to loading, targeted calf and plantar fascia stretching, and progressive strengthening — is essential to maximize the regenerative benefits of PRP and ensure lasting results. Most patients who do well with PRP are those who commit to the post-injection rehab process.
References
Rayo-Martín R, Rayo-Rosado R, Rayo-Pérez AM, Sánchez-Morilla S, Munuera-Martínez PV. Comparison of PRP injections versus corticosteroid injections in plantar fasciitis: systematic review and meta-analysis. Foot Ankle Spec. 2025. doi:10.1177/19386400251363002
Zuo A, Gao C, Jia Q, Zhang M, Fu T, Li T, Wang L. Platelet-rich plasma versus corticosteroids in the treatment of plantar fasciitis: a systematic review and meta-analysis. Am J Phys Med Rehabil. 2025;104(7):613-621. doi:10.1097/PHM.0000000000002677
Wang F, Meng F, Chan TCW, Wong SSC. Platelet-rich plasma for treating chronic noncancer pain: a systematic review and meta-analysis of randomized controlled trials. Pain Ther. 2025;14(4):1169-1188. doi:10.1007/s40122-025-00751-5
Latt LD, Jaffe DE, Tang Y, Taljanovic MS. Evaluation and treatment of chronic plantar fasciitis. Foot Ankle Orthop. 2020;5(1):2473011419896763. doi:10.1177/2473011419896763
Schedule an Appointment
If you are struggling with chronic plantar fasciitis or heel pain that has not responded to conservative treatments, I would be happy to evaluate your condition and discuss whether PRP injections may be right for you. Visit my sports medicine clinic page to learn more, or request an appointment to get started.

Comments